CDK2-IN-31 (compound I-125A) is a CDK2 inhibitor. CDK2-IN-31 can be used in cancer research[1].
IC 50
CDK2
References
[1] Yuanjin Zhang, et al. An allosteric cyclin E-CDK2 site mapped by paralog hopping with covalent probes. Nat Chem Biol. 2024 Sep 18. DOI:10.1038/s41589-024-01738-7